Accendra Health Inc. Common Stock
ACHUnited States
5 filed reports · 282 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 987 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 846 | Dec 2025 |
Financial data
282 concepts · 1,833 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial280 concepts · 1,734 facts · Dec 2023 to Jun 2026
- Common stock par or stated value per share14 · Dec 2023 to Jun 2026
- Restructuring reserve14 · Dec 2023 to Jun 2026
- Stockholders equity (US GAAP)14 · Dec 2023 to Jun 2026
- Net income loss13 · Dec 2023 to Jun 2026
- Other comprehensive income loss net of tax portion attributable to parent13 · Dec 2023 to Jun 2026
- Payments for restructuring13 · Dec 2023 to Jun 2026
- Acquisition-related charges and intangible amortization12 · Dec 2023 to Jun 2026
- Amortization of intangible assets12 · Dec 2023 to Jun 2026
- Business combination acquisition related costs12 · Dec 2023 to Jun 2026
- Comprehensive income net of tax12 · Dec 2023 to Jun 2026
- Cost of goods and service excluding depreciation depletion and amortization12 · Dec 2023 to Jun 2026
- Cost of goods and services sold depreciation12 · Dec 2023 to Jun 2026
- Cost of revenue (US GAAP)12 · Dec 2023 to Jun 2026
- Income tax expense benefit12 · Dec 2023 to Jun 2026
- Non-cash expenses conversion of equipment12 · Dec 2023 to Jun 2026
- Nonoperating income expense12 · Dec 2023 to Jun 2026
- Operating costs and expenses12 · Dec 2023 to Jun 2026
- Operating income loss12 · Dec 2023 to Jun 2026
- Other comprehensive income defined benefit plans adjustment before tax portion attributable to parent12 · Dec 2023 to Jun 2026
- Other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent12 · Dec 2023 to Jun 2026
- Other comprehensive income loss cash flow hedge gain loss after reclassification and tax parent12 · Dec 2023 to Jun 2026
- Other cost of operating revenue12 · Dec 2023 to Jun 2026
- Revenue12 · Dec 2023 to Jun 2026
- Revenue generated from equipment that is rented to patients12 · Dec 2023 to Jun 2026
Product2 concepts · 99 facts · Dec 2023 to Jun 2026
- Revenue90 · Dec 2023 to Jun 2026
- Selling general and administrative expense9 · Dec 2023 to Dec 2025
Segments
99 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service8 members · 99 facts
- Diabetes Product13 · Dec 2023 to Jun 2026
- Home Respiratory Therapy Product13 · Dec 2023 to Jun 2026
- Ostomy13 · Dec 2023 to Jun 2026
- Sleep Therapy Product13 · Dec 2023 to Jun 2026
- Urology13 · Dec 2023 to Jun 2026
- Wound Care13 · Dec 2023 to Jun 2026
- Product And Service Other12 · Dec 2023 to Jun 2026
- Shipping And Handling9 · Dec 2023 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Oct 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 10, 2026
- FY2026 Q1May 11, 2026
- FY2025 Q4Feb 19, 2026
- FY2025 Q3Oct 30, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.